Lou Chibbaro Jr.
Original Article: bit.ly/1zXN8MC
The director of the White House Office of National AIDS Policy and an official with a global pharmaceutical company released details at a White House meeting on Feb. 4 of two new initiatives aimed at curtailing the high rate of new HIV infections among black gay and bisexual men.
ONAP Director Douglas Brooks, who hosted the meeting, and Bill Collier, who heads the North American operation for the multi-national pharmaceutical firm ViiV Healthcare, discussed the two initiatives, which were launched separately last week by the U.S. Department of Health and Human Services and ViiV Healthcare.
Among those attending the meeting, which was billed as a roundtable discussion, were community leaders and federal government officials who work on HIV/AIDS related issues, according to a statement published on the HHS website AIDS.com. The event was closed to the media.
The statement says the event was timed to coincide with National Black HIV/AIDS Awareness Day, which took place two days later on Feb. 7.
The statement says Collier “announced a $10 million multi-year investment by the company to advance concerted community responses to the HIV epidemic among black gay, bisexual, and other men who have sex with men (MSM) in Baltimore, Md., and Jackson, Miss.”
Full text of article available at link below: bit.ly/1zXN8MC